Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yusuf C. Kaplan"'
Autor:
Kimberly Peven, Aidan P Wickham, Octavia Wilks, Yusuf C Kaplan, Andrei Marhol, Saddif Ahmed, Ryan Bamford, Adam C Cunningham, Carley Prentice, András Meczner, Matthew Fenech, Stephen Gilbert, Anna Klepchukova, Sonia Ponzo, Liudmila Zhaunova
Publikováno v:
JMIR mHealth and uHealth, Vol 11, p e46718 (2023)
BackgroundReproductive health conditions such as endometriosis, uterine fibroids, and polycystic ovary syndrome (PCOS) affect a large proportion of women and people who menstruate worldwide. Prevalence estimates for these conditions range from 5% to
Externí odkaz:
https://doaj.org/article/a27f2a74d01e4778ab0db20174d8af04
Autor:
Cécile Jaques, Cinzia Del Giovane, Alice Panchaud, Nazanin Abolhassani, Ursula Winterfeld, Yusuf C Kaplan, Beatrice Minder Wyssmann
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 11, Iss 1 (2023)
Metformin is considered as first-line treatment for type 2 diabetes and an effective treatment for polycystic ovary syndrome (PCOS). However, evidence regarding its safety in pregnancy is limited. We conducted a systematic review and meta-analysis of
Externí odkaz:
https://doaj.org/article/df08ee121e8847fd8ce63608ebf27743
Autor:
Gideon Koren, Yusuf C Kaplan
Publikováno v:
Clinical and Experimental Obstetrics & Gynecology, Vol 48, Iss 2, Pp 223-227 (2021)
Obesity is associated with twofold increased risk of neural tube defects (NTD). Research has repeatedly shown that about 70% of NTD are folic-acid dependent. Yet, there is controversy whether folic acid status is the main determinant of the increased
Externí odkaz:
https://doaj.org/article/ba68ccd4132e4c1fb207e1e92321731b
Autor:
Kimberly Peven, Aidan Wickham, Octavia Wilks, Yusuf C. Kaplan, Andrei Marhol, Saddif Ahmed, Ryan Bamford, Carley Prentice, Andras Meczner, Matthew Fenech, Stephen Gilbert, Anna Klepchukova, Sonia Ponzo
BackgroundReproductive health conditions such as endometriosis, uterine fibroids and polycystic ovary syndrome affect a large proportion of women and people who menstruate worldwide. Prevalence estimates for these conditions range from 5-40% of women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac92aaa2f6844e37a298206751207581
https://doi.org/10.1101/2023.02.22.23286305
https://doi.org/10.1101/2023.02.22.23286305
Autor:
Kimberly Peven, Aidan Wickham, Octavia Wilks, Yusuf C. Kaplan, Andrei Marhol, Saddif Ahmed, Ryan Bamford, Carley Prentice, András Meczner, Matthew Fenech, Stephen Gilbert, Anna Klepchukova, Sonia Ponzo
BACKGROUND Reproductive health conditions such as endometriosis, uterine fibroids and polycystic ovary syndrome affect a large proportion of women and people who menstruate worldwide. Prevalence estimates for these conditions range from 5-40% of wome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3ec65e94b1c8c7d220ac57609994c44
https://doi.org/10.2196/preprints.46718
https://doi.org/10.2196/preprints.46718
Autor:
Baris Karadas, Nusret Uysal, Hilal Erol, Selin Acar, Meltem Koc, Tijen Kaya‐Temiz, Gideon Koren, Yusuf C. Kaplan
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(9)
The objective of this meta-analysis was to determine whether maternal exposure to statins is associated with increased rates of major congenital malformations and other adverse pregnancy outcomes.PubMed/Medline, Web of Science and Reprotox® database
Autor:
Nazanin Abolhassani, Ursula Winterfeld, Yusuf C Kaplan, Cécile Jaques, Beatrice Minder Wyssmann, Cinzia Del Giovane, Alice Panchaud
Publikováno v:
Abolhassani, Nazanin; Winterfeld, Ursula; Kaplan, Yusuf C; Jaques, Cécile; Minder Wyssmann, Beatrice; Del Giovane, Cinzia; Panchaud, Alice (2023). Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis. BMJ open diabetes research & care, 11(1), e00291. BMJ Publishing Group 10.1136/bmjdrc-2022-002919
BMJ open diabetes research & care, vol. 11, no. 1, pp. e002919
BMJ open diabetes research & care, vol. 11, no. 1, pp. e002919
Metformin is considered as first-line treatment for type 2 diabetes and an effective treatment for polycystic ovary syndrome (PCOS). However, evidence regarding its safety in pregnancy is limited. We conducted a systematic review and meta-analysis of